These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36356866)

  • 1. Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
    Arif M; Ahmad R; Sharaf M; Samreen ; Muhammad J; Abdalla M; Eltayb WA; Liu CG
    Int J Biol Macromol; 2022 Dec; 223(Pt A):418-432. PubMed ID: 36356866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles.
    Moosazadeh Moghaddam M; Bolouri S; Golmohammadi R; Fasihi-Ramandi M; Heiat M; Mirnejad R
    J Mater Sci Mater Med; 2023 Aug; 34(9):44. PubMed ID: 37650975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering resveratrol-loaded chitosan nanoparticles for potential use against Helicobacter pylori infection.
    Spósito L; Fonseca D; Gonçalves Carvalho S; Sábio RM; Marena GD; Bauab TM; Bagliotti Meneguin A; Parreira P; L Martins MC; Chorilli M
    Eur J Pharm Biopharm; 2024 Jun; 199():114280. PubMed ID: 38588828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-curcumin complexation to develop functionalized nanosystems with enhanced antimicrobial activity against hetero-resistant gastric pathogen.
    Ejaz S; Ejaz S; Shahid R; Noor T; Shabbir S; Imran M
    Int J Biol Macromol; 2022 Apr; 204():540-554. PubMed ID: 35157901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
    Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
    Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
    Chehelgerdi M; Doosti A
    J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment.
    Fayed B; Jagal J; Cagliani R; Kedia RA; Elsherbeny A; Bayraktutan H; Khoder G; Haider M
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126706. PubMed ID: 37673144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of
    Arif M; Sharaf M; Samreen ; Khan S; Chi Z; Liu CG
    J Biomater Sci Polym Ed; 2021 Apr; 32(6):813-832. PubMed ID: 33428545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteria-targeting chitosan/carbon dots nanocomposite with membrane disruptive properties improve eradication rate of
    Arif M; Sharaf M; Samreen ; Dong Q; Wang L; Chi Z; Liu CG
    J Biomater Sci Polym Ed; 2021 Dec; 32(18):2423-2447. PubMed ID: 34644235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery LL37 by chitosan nanoparticles for enhanced antibacterial and antibiofilm efficacy.
    Rashki S; Safardoust-Hojaghan H; Mirzaei H; Abdulsahib WK; Mahdi MA; Salavati-Niasari M; Khaledi A; Khorshidi A; Mousavi SGA
    Carbohydr Polym; 2022 Sep; 291():119634. PubMed ID: 35698353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
    Gonçalves IC; Henriques PC; Seabra CL; Martins MC
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
    Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
    Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
    Li P; Chen X; Shen Y; Li H; Zou Y; Yuan G; Hu P; Hu H
    J Control Release; 2019 Apr; 300():52-63. PubMed ID: 30825476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
    Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of novel chitosan-Schiff bases nanoparticles for high efficiency Helicobacter pylori inhibition.
    Hamed AA; Ali EA; Abdelhamid IA; Saad GR; Elsabee MZ
    Int J Biol Macromol; 2024 Jun; 274(Pt 2):133499. PubMed ID: 38944085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo.
    Luo D; Guo J; Wang F; Sun J; Li G; Cheng X; Chang M; Yan X
    J Biomater Sci Polym Ed; 2009; 20(11):1587-96. PubMed ID: 19619399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro anti-inflammatory and anti-Helicobacter pylori activities of chitosan-based biomaterials modified with copper oxide nanoparticles.
    Elmehbad NY; Mohamed NA; Abd El-Ghany NA; Abdel-Aziz MM
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127277. PubMed ID: 37806410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CuO nanoparticles for green synthesis of significant anti-Helicobacter pylori compounds with in silico studies.
    Shehab WS; Elsayed DA; Abdel Hamid AM; Assy MG; Mouneir SM; Hamed EO; Mousa SM; El-Bassyouni GT
    Sci Rep; 2024 Jan; 14(1):1608. PubMed ID: 38238369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the Thermo-Stability and Anti-Bacterium Activity of Lysozyme by Immobilization on Chitosan Nanoparticles.
    Wang Y; Li S; Jin M; Han Q; Liu S; Chen X; Han Y
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.